-
PDF
- Split View
-
Views
-
Cite
Cite
Tristram A Lett, Bob O Vogel, Stephan Ripke, Carolin Wackerhagen, Susanne Erk, Swapnil Awasthi, Vassily Trubetskoy, Eva J Brandl, Sebastian Mohnke, Ilya M Veer, Markus M Nöthen, Marcella Rietschel, Franziska Degenhardt, Nina Romanczuk-Seiferth, Stephanie H Witt, Tobias Banaschewski, Arun L W Bokde, Christian Büchel, Erin B Quinlan, Sylvane Desrivières, Herta Flor, Vincent Frouin, Hugh Garavan, Penny Gowland, Bernd Ittermann, Jean-Luc Martinot, Marie-Laure Paillère Martinot, Frauke Nees, Dimitri Papadopoulos-Orfanos, Tomáš Paus, Luise Poustka, Juliane H Fröhner, Michael N Smolka, Robert Whelan, Gunter Schumann, Heike Tost, Andreas Meyer-Lindenberg, Andreas Heinz, Henrik Walter, IMAGEN consortium, Cortical Surfaces Mediate the Relationship Between Polygenic Scores for Intelligence and General Intelligence, Cerebral Cortex, Volume 30, Issue 4, April 2020, Pages 2708–2719, https://doi.org/10.1093/cercor/bhz270
Close -
Share
Abstract
Recent large-scale, genome-wide association studies (GWAS) have identified hundreds of genetic loci associated with general intelligence. The cumulative influence of these loci on brain structure is unknown. We examined if cortical morphology mediates the relationship between GWAS-derived polygenic scores for intelligence (PSi) and g-factor. Using the effect sizes from one of the largest GWAS meta-analysis on general intelligence to date, PSi were calculated among 10 P value thresholds. PSi were assessed for the association with g-factor performance, cortical thickness (CT), and surface area (SA) in two large imaging-genetics samples (IMAGEN N = 1651; IntegraMooDS N = 742). PSi explained up to 5.1% of the variance of g-factor in IMAGEN (F1,1640 = 12.2–94.3; P < 0.005), and up to 3.0% in IntegraMooDS (F1,725 = 10.0–21.0; P < 0.005). The association between polygenic scores and g-factor was partially mediated by SA and CT in prefrontal, anterior cingulate, insula, and medial temporal cortices in both samples (PFWER-corrected < 0.005). The variance explained by mediation was up to 0.75% in IMAGEN and 0.77% in IntegraMooDS. Our results provide evidence that cumulative genetic load influences g-factor via cortical structure. The consistency of our results across samples suggests that cortex morphology could be a novel potential biomarker for neurocognitive dysfunction that is among the most intractable psychiatric symptoms.
Introduction
General intelligence (g-factor) is the primary component and predictor of performance on diverse psychometric tasks (Carroll 1993; Gray and Thompson 2004). These neurocognitive tasks are intercorrelated with one component consistently predicting approximately 40–45% of the variance (Carroll 1993; Jensen 1998a). Some life outcomes correlate with g-factor including physical and mental health, as well as job performance (Strenze 2007; Deary et al. 2018). Full-scale IQ measures and g-factor are distinct measures of intelligence in that IQ results from summation of standardized scores across several tests. These measures are generally highly correlated. However, g-factor is an important component of IQ, but IQ is a specific mixture of cognitive abilities and skills that may not be represented by g-factor (Colom et al. 2002).
Cortical brain volumes are associated with g-factor (Thompson et al. 2001; Posthuma et al. 2002; Haier et al. 2004; Mcdaniel 2005). Although global effects have been reported, g-factor performance is most commonly associated with the dorsolateral prefrontal cortex (DLPFC), medial temporal lobes, anterior and posterior cingulate, and inferior parietal lobes (Haier et al. 2004; Toga and Thompson 2005; Narr et al. 2006; Basten et al. 2015). The heritability observed in g-factor and IQ may be shared among volumetric measures of cortical structure (Posthuma et al. 2002; Davies et al. 2018a; Elliott et al. 2018a; Savage et al. 2018) and potentially epigenetic variation (Kaminski et al. 2018). However, the association between cortical volume and g-factor may be more complex as cortical thickness (CT) and surface area (SA) have distinct genetic contributions and developmental trajectories (Panizzon et al. 2009; Winkler et al. 2010; Hogstrom et al. 2013; Jha et al. 2018). CT and SA also have been associated with intelligence throughout the lifespan (Narr et al. 2006; Karama et al. 2011; Schnack et al. 2015; Schmitt et al. 2019). In particular, changes in CT in frontotemporal and inferior parietal regions during development have been shown to mediate the heritability of IQ. The heritability of g-factor has also been associated with brain volume differences in the same cortical regions, and these regions may partially share the genetic influences of neuropsychiatric disorders on brain structure (Toga and Thompson 2005).
The interindividual differences in g-factor performance have significant genetic and environmental contributions (Deary et al. 2009; Plomin et al. 2012). A conservative estimate for the heritability of g-factor is approximately 40% (Bouchard and McGue 1981; Deary et al. 2010; Haworth et al. 2010; Plomin and Deary 2015; Kaminski et al. 2018). Until recently, the contribution of common genetic variants accounting for this heritability was unclear. Several smaller GWAS identified tens of independent genetic loci associated with cognitive functioning (Davies et al. 2011, 2015, 2016; Benyamin et al. 2014; Kirkpatrick et al. 2014; Lencz et al. 2014; Lam et al. 2017; Sniekers et al. 2017; Trampush et al. 2017). More recently, a large genome-wide association meta-analysis uncovered 205 associated genomic loci and 1016 genes that were statistically related to general intelligence in 269 867 participants (Savage et al. 2018). Another study with large sample overlap with Savage et al. (2018), identified 148 independent loci and 709 genes influencing general cognitive function in 300 486 individuals (Davies et al. 2018b). Polygenic scores based on the recent GWAS studies explained approximately 2.0–5.2% of the variance in general intelligence (Davies et al. 2018b; Savage et al. 2018). There was also a robust genetic correlation, but with small effect size (rg~ − 0.20), of polygenic scores for intelligence with neuropsychiatric disorders with prominent cognitive symptoms including schizophrenia (SCZ) (Ohi et al. 2018; Savage et al. 2018). It has been reported that the genetic correlation with general cognitive function may be protective or mitigate the diagnosis of psychiatric disorders (Lam et al. 2017; Sniekers et al. 2017; Trampush et al. 2017; Davies et al. 2018b; Savage et al. 2018). These genetic findings represent an important step to further elucidating the architecture of human intelligence and potential neurobiological mechanisms underlying cognitive impairment in psychiatric disorders.
Lower g-factor scores and IQ impairment have been reported among many neuropsychiatric disorders including SCZ (Heinrichs and Zakzanis 1998; Heaton et al. 2001), bipolar disorder (BPD) (Bora and Pantelis 2015), major depressive disorder (MDD) (Rock et al. 2014), attention deficit hyperactivity disorder (Hill et al. 2016), and autism spectrum disorder (ASD) (Millan et al. 2012). The neurocognitive domains contributing to lower g-factor scores vary among individuals and clinical subpopulations of these diseases. Moreover, the causes of neurocognitive impairment may be different between these disorders. For instance, an MDD patient may have dysfunction due to an acute depressive episode in contrast to persistent cognitive symptoms in some chronic schizophrenia patients. Among psychiatric patients, neurocognitive symptoms have a negative impact on quality of life, social functioning, and occupational functioning (Green 2006; McIntyre et al. 2013). Cognitive impairments are particularly severe in some patients with ASD and SCZ in which cognitive deficits are a core feature of the disorders that are highly prevalent, manifest early, are relatively stable over time, and correlate with overall symptom severity (Seidman 2006; Savilla et al. 2008; Hill et al. 2016). Impairment is also present in first-degree relatives of patients suggesting a genetic component that is not a downstream effect of the disease process (Clark et al. 2005; Snitz et al. 2006; Bora et al. 2009; Gau and Shang 2010; Rommelse et al. 2011). Therefore, g-factor has been argued to be an important endophenotype among psychiatric populations (e.g., Burdick et al. 2009).
In the present study, we used genome-wide, whole-brain neuroimaging, and neurocognitive performance data from two large independent samples: the naturalistic adolescent development cohort IMAGEN study (N = 1651) and the cross-psychiatric disorder IntegraMooDS sample (N = 742) that includes healthy controls, as well as patients and first-degree relatives of patients with MDD, BPD, and SCZ. Our primary goal was to investigate the mechanistic relationship among the polygenic intelligence scores (PSi), derived from the Savage et al. 2018 intelligence, wave 2 study (Savage et al. 2018), cortical structure, and g-factor performance, which requires a number of intermediary steps. First, we aimed to validate the association between polygenic scores and g-factor. Second, we assessed the association of g-factor performance with vertex-wise measures of CT and SA. Third, we established PSi (thresholds ranging from PT < 5.0 × 10−8 to PT = 1.0) that were associated with CT and SA. Last, we aimed to use vertex-wise putative causal models to assess if the association between PSi and g-factor performance was mediated by cortical brain structure in youths, adults, relatives of patients, and patients.
Materials and Methods
Subjects
We analyzed two independent samples with neuroimaging, neurocognitive, and genome-wide genotype data. The first sample (IMAGEN; www.imagen-europe.com; N = 1651) is a large-scale, longitudinal European imaging genetics study. It is a community-based sample of adolescents with Caucasian origin that was collected at eight different sites in Europe: Berlin, Germany (N = 214); Dresden, Germany (N = 239); Dublin, Ireland (N = 154); Hamburg, Germany (N = 215); London, England (N = 186); Mannheim, Germany (N = 192); Nottingham, England (N = 257); and Paris, France (N = 194). The average age was 13.9 ± 0.45 including 817 males and 834 females. A detailed description of the IMAGEN sample has been provided in earlier publications (Schumann et al. 2010; Kaminski et al. 2018). The ethics committees approved the study among clinical sites. Legal guardians of participants provided written informed consent prior to commencement of the study.
The newly completed, cross-psychiatric disorder IntegraMooDS sample (N = 742) consists of healthy controls (N = 339), first-degree relatives of MDD (rel-MDD; N = 91), BPD (rel-BPD; N = 69) and SCZ (rel-SCZ; N = 67), and independent subgroups of patients with MDD (pat-MDD; N = 67), BPD (pat-BPD; N = 60), and SCZ (pat-SCZ; N = 50; Table S1). The Structured Clinical Interview of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) Axis-I Disorders (SCID-I) (First and Spitzer 2002) was used to confirm diagnosis of patients and to ensure that relatives and controls never suffered from a psychiatric disorder. Symptom severity was assessed using the SCL-90-R (Derogatis 1979) (Table S1). All participants reported having grandparents of European origin. Medication information is listed in Table S2. Data of IntegraMooDS participants were collected across three different German research institutions: Central Institute of Mental Health at the University of Heidelberg, Mannheim; Department of Psychiatry and Psychotherapy, University of Bonn, Bonn; and the Department of Psychiatry and Psychotherapy at Charité-Universitätsmedizin Berlin. The ethics committees of the participating centers approved the study and all participants provided written informed consent prior to commencement of the study. IMAGEN and IntegraMooDS were both conducted in accordance with the Declaration of Helsinki.
General Intelligence
Using standard methods (Spearman 1904; Mackintosh 2011; Davies et al. 2016; Savage et al. 2018), g-factor was defined as the first principal component among psychometric neurocognitive batteries encompassing multiple dimensions of cognitive functioning. Since IMAGEN and IntegraMooDS have different neurocognitive batteries, we conducted a principal component analysis (PCA) of the different cognitive tests available and selected the first unrotated component independently in each sample. In IMAGEN, g-factor was calculated from the WISC-IV (Feis 2010) including: matrix reasoning, block design, digit span backward and forward, similarities and vocabulary. In IntegraMooDS, we conducted PCA from the Hamburg-Wechsler Adult Intelligence Scale (HAWIE-R) (Wechsler 2008) subtests digit span memory test (forwards and backwards), matrix reasoning, digit symbol, and additional neurocognitive tests including verbal fluency (Aschenbrenner et al. 2000), verbal intelligence (Lehrl 1993), verbal learning and memory (Helmstaedter 2001), trail making test version a and b (Giovagnoli et al. 1996), and d2 concentration performance (Brickenkamp and Zillmer 1998). In both samples, the factor loadings of individual neurocognitive tests followed a typical pattern (Deary et al. 2010) and correlated highly with the extracted g-factor (all r > 0.47; Fig. S1). In general, g-factor scores are relatively stable even when calculated from a variety of cognitive tests (Jensen 1998b). For instance, g-factor scores obtained from different domains of cognitive tests correlate highly (r > 0.98; Johnson et al. 2004; Johnson et al. 2008). In previous studies, g-factor generally accounts for 40% or more of the variance across different cognitive domains (Carroll 1993; Deary et al. 2010). A detailed description of the different neuropsychological tests used in both samples is shown in the intelligence measures section of the Supplementary Material.
Genetics
Quality control, imputation, and analysis of the genetic data for both the IMAGEN and IntegraMooDS samples was performed according to the standards of the Psychiatric Genomics Consortium (PGC; http://www.med.unc.edu/pgc; for further details see Supplementary Material, Genetics section). IMAGEN was a minor contribution to the original study conducted by Savage et al. (2018). To avoid bias, we were provided with the summary statistics by the authors excluding IMAGEN. This resulted in 268 524 individuals from the original GWAS with 9 270 275 SNPs instead of the 269 867 individuals included in the publication. Polygenic scores are used to summarize genome-wide effects among sets of genetic variants that may not achieve significance alone in large-scale association studies (Dudbridge 2013). Among genetically complex phenotypes, in which thousands of genetic polymorphisms may be contributing to the trait, these aggregated polygenic scores increase the predictive power that would not be achievable by a single variant alone (Dudbridge 2013). We used the latest general intelligence meta-analysis conducted by Savage et al. (2018) to calculate PSi for each individuals in both samples as the weighted sum of the alleles associated with lower general intelligence. For each individual, we calculated 10 PSi deciles at P-value thresholds ranging from P = 1 to P < 0.5 × 10−8. Our thresholds, and the method in general, are standard among PGC publications (for further details, Supplementary Material, Genetics section) (Ripke et al. 2014; Cross-Disorder Group of the PGC 2013; Purcell et al. 2009). Genetic population stratification was assessed among the first four genetic principal components (IMAGEN: Fig. S3; IntegraMooDS: Fig. S4).
Image Acquisition
In IMAGEN, the image acquisition parameters and preprocessing steps have been described in detail in a prior publication (Schumann et al. 2010), and they are summarized in the image acquisition section of the Supplementary Material. In IntegraMooDS, scans were acquired using three Siemens Trio 3 T MR (Siemens) scanners at Charité Universitätsmedizin Berlin, at the Life and Brain Center of the University of Bonn, and at the Zentralinstitut für seelische Gesundheit, Mannheim. Image acquisition parameters and processing of structural images are described in detail in prior publications (Lett et al. 2017; Vogel et al. 2018), and in the methods section of the Supplementary Material.
Statistical Analysis
Our statistical models were different in IMAGEN and IntegraMooDS. In IMAGEN, we included sex, age, site, and the top four principal components (PCs) from the population stratification analysis as covariates. In IntegraMooDS, we additionally included the subgroups (healthy controls, rel-MDD, rel-BPD, rel-SCZ, pat-MDD, pat-BPD, and pat-SCZ) as covariates along with sex, age, site, and the top four PCs from the population stratification analysis. In follow-up analyses, we determined if we should be including the cross-diagnostic subgroups in IntegraMooDS as an interacting variable with each PSi for both the main effects (i.e., PSi on cortical structure), as well as the mediation effects (i.e., PSi on g-factor via cortical structure). In both samples, linear regression was applied to investigate the association between PSi and general intelligence. In IntegraMooDS, we followed-up this analysis examining PSi by subgroup interactions.
Neuroimaging Analysis
For vertex-wise analyses of cortical surfaces, the TFCE_mediation toolbox (Lett et al. 2017) was used (https://github.com/trislett/TFCE_mediation). The toolbox performs threshold-free cluster enhancement (TFCE) transformation on vertex-wise statistic images (Smith and Nichols, 2009). Significance of the TFCE-transformed statistic image is assessed via permutation testing after correcting for family-wise error rate (PFWER-corrected). The toolbox also allows for cortex-wise mediation analyses. For all neuroimaging analyses, significance was determined after 10 000 permutations at a PFWER- corrected < 0.05 and PFWER- corrected < 0.005 for analyses that included PSi.
Cortex-wise mediation is explained in detail in the Supplementary Material, as well as in prior publications (Lett et al. 2016, 2017, 2018). This analysis allowed us to determine if the associations between PSi and g-factor were independent of differences in SA and CT, or if SA and CT were mediating the effect. The mediation models in IMAGEN and IntegraMooDS were performed with PSi as independent variable, vertex-wise SA, or CT were the mediator variables, and g-factor was the dependent variable. At each vertex, the indirect effect was assessed using the Sobel Test Z-statistic (Sobel 1986). The Z-statistic images then underwent TFCE, and significance of cortex-wise mediation was determined after 10 000 permutations.
Post hoc Estimation of Effect Sizes
Results
General Intelligence
In IMAGEN, g-factor explained 41.1% variance and 41.7% of the variance in IntegraMooDS (Fig. S1). In both samples, g-factor explained a similar amount of variance across various cognitive tests (Table S3; Fig. S2). Within IntegraMooDS, g-factor was significantly different between subgroups (F6,726 = 9.34, P = 1.8 × 10−9, Fig. S5). Pairwise comparisons revealed that g-factor was significantly lower in rel-SCZ, pat-BPD, and pat-SCZ compared to healthy controls, with the greatest difference in pat-SCZ compared to control subjects (Table S4).
Polygenic Intelligence Score
In both samples, PS1–PS10 correlated positively with each other after correction for multiple testing indicating a relatively high degree of collinearity among PSi (IMAGEN: r = 0.23–0.99, P < 1.2 × 10−20; IntegraMooDS: r = 0.30–0.99, P < 8.5 × 10−17; Fig. S6). In IntegraMooDS, the PS1–PS10 did not differ significantly between subgroups (F6,727 = 0.33–1.86, P > 0.05).
Association of Polygenic Scores with General Intelligence
In the IMAGEN sample, PS1–PS10 were associated with g-factor with PS6–PS8 explaining approximately 5.1% of the variance (F1,1640 = 12.23–94.30; P < 0.005; Fig. 1). In the IntegraMooDS sample, PS2–PS10 were associated with g-factor with PS5 explaining 3.0% of the variance (F1,725 = 9.99–20.98; P < 0.005; Fig. 1). In follow-up analyses, we included the interaction between PSi and IntegraMooDS subgroups. There were no significant subgroups by PSi interactions on g-factor at all PSi thresholds (F6,720 = 0.31–1.03, P > 0.05).
Effect sizes (partial eta squared) of associations between polygenic scores for general intelligence ranging from PS1 to PS10 and g-factor performance. All polygenic scores were significantly associated with g-factor after Bonferroni correction for 10 multiple comparisons (IMAGEN: F1,1640 = 12.23–94.30; IntegraMooDS: F1,725 = 9.99–20.98; all Pcorrected < 0.05) except PS1, which was nominally associated with g-factor in IntegraMooDS (F1,725 = 5.09; P < 0.05).
Association Among g-factor, Cortical Thickness and Surface Area
In IMAGEN, vertex-wise analysis of CT and SA revealed a positive association with g-factor throughout the cortex (PFWER-corrected < 0.05; Fig. S7). This global effect was also observed in IntegraMooDS where increased CT and SA were associated with g-factor performance (PFWER-corrected < 0.05; Fig. S7).
Association of Polygenic Scores and Brain Structure
Cortical Thickness
Within IMAGEN, PS3–PS8 (PT < 1.0 × 10−4 to PT < 0.2) were associated with higher CT (PFWER-corrected < 0.005; Table 1, Table S5) in the prefrontal cortices, anterior cingulate, insula, medial temporal cortex, and inferior parietal cortex (Fig. S8 for PS4). Within the IntegraMooDS sample, PS2, PS4, and PS5 were associated with higher CT in similar regions as in IMAGEN (bilateral prefrontal cortex, anterior cingulate, insula, temporal cortex, and inferior parietal cortex; PFWER-corrected < 0.005; Table 1, Table S5, Fig. S8 for PS4 vertex-wise results). Vertex-wise results for PSi scores at PFWER-corrected < 0.05 and PFWER-corrected < 0.005 are available in the Supplementary Material under online vertex-wise results. In follow-up analysis, there was no significant PSi by subgroup interaction in the IntegraMooDS sample (PFWER-corrected > 0.05).
Associations of polygenic scores for general intelligence and surface area as well as cortical thickness in IMAGEN and IntegraMooDS at two different thresholds, separately for main effects and mediation analyses (indirect effect).
| . | Cortical thickness . | Surface area . | ||
|---|---|---|---|---|
| Main effect . | IMAGEN . | IntegraMooDS . | IMAGEN . | IntegraMooDS . |
| PS1 (PT < 5.0 × 10−8) | - | * | - | - |
| PS2 (PT < 1.0 × 10−6) | * | *** | * | *** |
| PS3 (PT < 1.0 × 10−4) | *** | * | *** | * |
| PS4 (PT < 0.001) | *** | *** | *** | *** |
| PS5 (PT < 0.01) | *** | *** | *** | *** |
| PS6 (PT < 0.05) | *** | * | *** | * |
| PS7 (PT < 0.1) | *** | * | * | * |
| PS8 (PT < 0.2) | *** | * | * | *** |
| PS9 (PT < 0.5) | * | * | * | * |
| PS10 (PT < 1.0) | * | * | - | * |
| Indirect Effect | IMAGEN | IntegraMooDS | IMAGEN | IntegraMooDS |
| PS1 (PT < 5.0 × 10−8) | - | *** | - | - |
| PS2 (PT < 1.0 × 10−6) | * | *** | * | *** |
| PS3 (PT < 1.0 × 10−4) | *** | *** | *** | *** |
| PS4 (PT < 0.001) | *** | *** | *** | *** |
| PS5 (PT < 0.01) | *** | *** | *** | *** |
| PS6 (PT < 0.05) | *** | * | *** | * |
| PS7 (PT < 0.1) | *** | * | *** | *** |
| PS8 (PT < 0.2) | *** | * | *** | *** |
| PS9 (PT < 0.5) | * | * | * | *** |
| PS10 (PT < 1.0) | * | * | - | *** |
| . | Cortical thickness . | Surface area . | ||
|---|---|---|---|---|
| Main effect . | IMAGEN . | IntegraMooDS . | IMAGEN . | IntegraMooDS . |
| PS1 (PT < 5.0 × 10−8) | - | * | - | - |
| PS2 (PT < 1.0 × 10−6) | * | *** | * | *** |
| PS3 (PT < 1.0 × 10−4) | *** | * | *** | * |
| PS4 (PT < 0.001) | *** | *** | *** | *** |
| PS5 (PT < 0.01) | *** | *** | *** | *** |
| PS6 (PT < 0.05) | *** | * | *** | * |
| PS7 (PT < 0.1) | *** | * | * | * |
| PS8 (PT < 0.2) | *** | * | * | *** |
| PS9 (PT < 0.5) | * | * | * | * |
| PS10 (PT < 1.0) | * | * | - | * |
| Indirect Effect | IMAGEN | IntegraMooDS | IMAGEN | IntegraMooDS |
| PS1 (PT < 5.0 × 10−8) | - | *** | - | - |
| PS2 (PT < 1.0 × 10−6) | * | *** | * | *** |
| PS3 (PT < 1.0 × 10−4) | *** | *** | *** | *** |
| PS4 (PT < 0.001) | *** | *** | *** | *** |
| PS5 (PT < 0.01) | *** | *** | *** | *** |
| PS6 (PT < 0.05) | *** | * | *** | * |
| PS7 (PT < 0.1) | *** | * | *** | *** |
| PS8 (PT < 0.2) | *** | * | *** | *** |
| PS9 (PT < 0.5) | * | * | * | *** |
| PS10 (PT < 1.0) | * | * | - | *** |
Note. * represents the family-wise error-rate-corrected significance threshold (PFWER-corrected < 0.05). *** represents significant P values after correcting for 10 multiple comparisons as well as family-wise error rate (PFWER-corrected < 0.005). PT, polygenic score threshold.
Associations of polygenic scores for general intelligence and surface area as well as cortical thickness in IMAGEN and IntegraMooDS at two different thresholds, separately for main effects and mediation analyses (indirect effect).
| . | Cortical thickness . | Surface area . | ||
|---|---|---|---|---|
| Main effect . | IMAGEN . | IntegraMooDS . | IMAGEN . | IntegraMooDS . |
| PS1 (PT < 5.0 × 10−8) | - | * | - | - |
| PS2 (PT < 1.0 × 10−6) | * | *** | * | *** |
| PS3 (PT < 1.0 × 10−4) | *** | * | *** | * |
| PS4 (PT < 0.001) | *** | *** | *** | *** |
| PS5 (PT < 0.01) | *** | *** | *** | *** |
| PS6 (PT < 0.05) | *** | * | *** | * |
| PS7 (PT < 0.1) | *** | * | * | * |
| PS8 (PT < 0.2) | *** | * | * | *** |
| PS9 (PT < 0.5) | * | * | * | * |
| PS10 (PT < 1.0) | * | * | - | * |
| Indirect Effect | IMAGEN | IntegraMooDS | IMAGEN | IntegraMooDS |
| PS1 (PT < 5.0 × 10−8) | - | *** | - | - |
| PS2 (PT < 1.0 × 10−6) | * | *** | * | *** |
| PS3 (PT < 1.0 × 10−4) | *** | *** | *** | *** |
| PS4 (PT < 0.001) | *** | *** | *** | *** |
| PS5 (PT < 0.01) | *** | *** | *** | *** |
| PS6 (PT < 0.05) | *** | * | *** | * |
| PS7 (PT < 0.1) | *** | * | *** | *** |
| PS8 (PT < 0.2) | *** | * | *** | *** |
| PS9 (PT < 0.5) | * | * | * | *** |
| PS10 (PT < 1.0) | * | * | - | *** |
| . | Cortical thickness . | Surface area . | ||
|---|---|---|---|---|
| Main effect . | IMAGEN . | IntegraMooDS . | IMAGEN . | IntegraMooDS . |
| PS1 (PT < 5.0 × 10−8) | - | * | - | - |
| PS2 (PT < 1.0 × 10−6) | * | *** | * | *** |
| PS3 (PT < 1.0 × 10−4) | *** | * | *** | * |
| PS4 (PT < 0.001) | *** | *** | *** | *** |
| PS5 (PT < 0.01) | *** | *** | *** | *** |
| PS6 (PT < 0.05) | *** | * | *** | * |
| PS7 (PT < 0.1) | *** | * | * | * |
| PS8 (PT < 0.2) | *** | * | * | *** |
| PS9 (PT < 0.5) | * | * | * | * |
| PS10 (PT < 1.0) | * | * | - | * |
| Indirect Effect | IMAGEN | IntegraMooDS | IMAGEN | IntegraMooDS |
| PS1 (PT < 5.0 × 10−8) | - | *** | - | - |
| PS2 (PT < 1.0 × 10−6) | * | *** | * | *** |
| PS3 (PT < 1.0 × 10−4) | *** | *** | *** | *** |
| PS4 (PT < 0.001) | *** | *** | *** | *** |
| PS5 (PT < 0.01) | *** | *** | *** | *** |
| PS6 (PT < 0.05) | *** | * | *** | * |
| PS7 (PT < 0.1) | *** | * | *** | *** |
| PS8 (PT < 0.2) | *** | * | *** | *** |
| PS9 (PT < 0.5) | * | * | * | *** |
| PS10 (PT < 1.0) | * | * | - | *** |
Note. * represents the family-wise error-rate-corrected significance threshold (PFWER-corrected < 0.05). *** represents significant P values after correcting for 10 multiple comparisons as well as family-wise error rate (PFWER-corrected < 0.005). PT, polygenic score threshold.
Surface Area
In IMAGEN, higher PS3–PS5 were associated with larger SA (PFWER-corrected < 0.005; Table 1). The positive association between PSi and SA was prominently observed in the frontal cortices, including bilateral DLPFC, as well as the anterior cingulate, insula, medial temporal cortex, and the inferior parietal cortex (Fig. S8 for PS4 vertex-wise results). In IntegraMooDS, higher PS2, PS4, PS5, and PS8 were associated with larger SA in similar regions as in IMAGEN (prefrontal cortices, anterior cingulate, insula, temporal cortex, and inferior parietal cortex) (PFWER-corrected < 0.005; Table 1; Table S6). Vertex-wise results for PSi scores at PFWER-corrected < 0.05 and PFWER-corrected < 0.005 are available in the Supplementary Material under online vertex-wise results. Follow-up analysis revealed that there were no significant PSi by subgroup interactions in the IntegraMooDS sample (PFWER-corrected > 0.05).
Cortex-wise Mediation Analyses
Cortical Thickness
In IMAGEN, CT partially mediated the relationship between PS3 to PS8 and g-factor (PFWER-corrected < 0.005; Table 1; Table S7). The mediation was primarily in the prefrontal cortices, anterior cingulate, insula, medial temporal cortex, and inferior parietal cortex (Fig. 2 for PS4). Within the IntegraMooDS sample, CT mediated the relationship between PS2–PS5 and g-factor in similar regions as IMAGEN (PFWER-corrected < 0.005; Table 1; Table S7; Fig. 2 for PS4). Vertex-wise results for PSi scores at PFWER-corrected < 0.05 and PFWER-corrected < 0.005 are available in the Supplementary Material under online vertex-wise results. We did not include IntegraMooDS subgroup as an interacting variable in the mediation model because there were no significant PSi by subgroup interaction on CT (PFWER-corrected > 0.05).
The association of PS4 (PT < 0.001) and g-factor is mediated by cortical thickness in key regions associated with general intelligence in IMAGEN (N = 1651) and IntegraMooDS (N = 742). Significant vertices are shown ranging from PFWER-corrected < 0.005 (red) to PFWER-corrected < 0.001 (yellow). (A) Mediation model statistics from the largest significant cluster (Supplementary Table S7) for associations among PS4, cortical thickness, and g-factor in IMAGEN. Solid arrows represent direct effects, and the dotted arrow represents the indirect effect of PS4 on g-factor. (B) Brain orientation labels in clockwise direction: rostral, left, superior, inferior, right, caudal. (C) Mediation model statistics from the largest significant cluster (Supplementary Table S7) for associations among PS4, cortical thickness, and g-factor in IntegraMooDS. Solid arrows represent direct effects, and the dotted arrow represents the indirect effect of PS4 on g-factor. (D) Brain orientation labels in clockwise direction: rostral, left, superior, inferior, right, caudal.
Surface Area
In IMAGEN, the association between PSi and g-factor was partially mediated by SA, particularly in the prefrontal cortices, including bilateral DLPFC, as well as anterior cingulate, insula, medial temporal cortex, and inferior parietal cortex (Fig. 3 for PS4 vertex-wise results). SA mediated the relationship between PS4–PS8 and g-factor (PFWER-corrected < 0.005; Table S8). Within the IntegraMooDS sample, SA mediated the relationship between PS2–PS5 and PS6–PS10 and g-factor in similar regions as IMAGEN (PFWER-corrected < 0.05; Table 1; Table S8; Fig. 3 for PS4). Vertex-wise results for PSi scores at PFWER-corrected < 0.05 and PFWER-corrected < 0.005 are available in the Supplementary Material under online vertex-wise results. We did not include IntegraMooDS subgroup as an interacting variable in the mediation model because there was no significant PSi by subgroup interaction on SA (PFWER-corrected > 0.05).
The association of PS4 (PT < 0.001) and g-factor is mediated by surface area in key regions associated with general intelligence in IMAGEN (N = 1651) and IntegraMooDS (N = 742). Significant vertices are shown ranging from PFWER-corrected < 0.005 (red) to PFWER-corrected < 0.001 (yellow). (A) Mediation model statistics from the largest significant cluster (Supplementary Table S8) for associations among PS4, surface area and g-factor in IMAGEN. Solid arrows represent direct effects, and the dotted arrow represents the indirect effect of PS4 on g-factor. (B) Brain orientation labels in clockwise direction: rostral, left, superior, inferior, right, caudal. (C) Mediation model statistics from the largest significant cluster (Supplementary Table S8) for associations among PS4, surface area, and g-factor in IntegraMooDS. Solid arrows represent direct effects, and the dotted arrow represents the indirect effect of PS4 on g-factor. (D) Brain orientation labels in clockwise direction: rostral, left, superior, inferior, right, caudal.
Post hoc Estimation of the Mediation Effects
We estimated the post hoc effect sizes from the mean top cluster values of the vertex-wise mediation analyses (Table 1, Figs. 2–3, and Tables S6–S8). For the direct effect, associations between PSi and g-factor, the partial η2 of the ranged from 0.007–0.054 in IMAGEN and 0.014–0.028 in IntegraMooDS (Fig. 1, Table S9). The variance explained for PSi, on CT ranged from partial η2 = 0.009 to 0.017 in IMAGEN, and partial η2 = 0.019 to 0.034 in IntegraMooDS, and the variance explained for PSi on SA ranged from partial η2 = 0.005 to 0.013 in IMAGEN and partial η2 = 0.012 to 0.023 in IntegraMooDS (Table S9).
The indirect effect of PSi and g-factor via the top CT clusters ranged from partial η2 = 0.0028 to 0.0075 in IMAGEN and partial η2 = 0.0019 to 0.0076 in IntegraMooDS (Table S9). Of the explainable variance in g-factor by PSi, the indirect effect explained ranged between 10.7%–24.9% in IMAGEN and 12.2%–41.0% in IntegraMooDS. The indirect effect of PSi and g-factor via CT ranged from partial η2 = 0.0021 to 0.0065 in IMAGEN and partial η2 = 0.0029 to 0.0062 in IntegraMooDS (Table S9). Of the explainable variance in g-factor, the indirect effect of the SA explained between 6.3%–18.9% in IMAGEN and 17.7%–32.3% in IntegraMooDS (Table S9).
Discussion
It has been reported that the genetic contribution to general intelligence is partially shared with the genetics of cortical structure (Grasby et al. 2018; Savage et al. 2018). To the best of our knowledge, we provide first direct evidence that the genetic influence of common variants on general intelligence is partially mediated by its intermediate effect on CT and SA. Individuals with higher PSi scores, particularly at the PT < 0.001 threshold (PS4), had higher CT and SA in the frontotemporal, inferior parietal, and anterior cingulate regions that putatively led to better g-factor performance. These results were remarkably consistent among 14-year-old adolescents in the IMAGEN sample, as well as among the adult subgroups of the IntegraMooDS sample, suggesting that PSi may be independent of the subject population. Moreover, we potentially validate the functional effect of our SNP-derived PSi since the cortical regions that mediate genetic effects on g-factor are similar to the regions associated with intelligence identified in twin-based heritability studies. All in all, we provide functional evidence that the cortical regions associated with the PSi may be integral to interindividual differences in g-factor performance.
Among the IMAGEN and IntegraMooDS samples, we found remarkably consistent associations among: (1) PSi and g-factor, (2) PSi and cortical structure, and (3) cortical structure and g-factor. We demonstrated consistent associations between PSi and g-factor performance in IMAGEN and IntegraMooDS with variance explained maximizing around the PT < 0.001 threshold (PS4). Importantly, it should be noted that we derived our PSi from a subsample of the meta-analysis that excluded IMAGEN. We replicated the Savage et al. (2018) PSi association with intelligence in the cross-disorder IntegraMooDS sample, and in both samples, the maximum PSi was around PT < 0.001 polygenic threshold (PS4) (Savage et al. 2018). Importantly, PSi was also robustly associated with CT and SA in prefrontal, medial temporal, anterior cingulate, parietal, and insular cortices in both samples even after correcting for 10 PSi thresholds and FWER across all vertices (approximately 3 million vertices in total). The topography of these associations is consistent with regions that have been heavily implicated by structural and functional neuroimaging studies in neurocognitive capacity (Deary et al. 2010; Basten et al. 2015; Pietschnig et al. 2015). The associated regions are also consistent to previously reported areas that have high heritability and are associated with general intelligence (Thompson et al. 2001; Gray and Thompson 2004; Toga and Thompson 2005; Narr et al. 2006). Within our samples, there were brain-wide positive correlations among CT and SA and g-factor performance. The unspecific effect of cortex morphology on g-factor performance is consistent with recent meta-analytic data, demonstrating robust associations between general cognitive function and total brain volume (Elliott et al. 2018b). This result is also consistent with general associations with most structural MRI phenotypes (Ritchie et al. 2015) and intelligence including CT (Shaw et al. 2006; Karama et al. 2011) and SA (Lencz et al. 2014). Therefore, a natural question is if there is a latent association among these three correlations.
To date, the majority of neuroimaging and genetics studies examining cognition have focused on pairwise relationships among genetics-cognition, genetics-brain, or brain-cognition. We performed vertex-wise mediation analysis of CT and SA among 10 PSi thresholds in two independent samples linking genetics, brain structure, and general intelligence. Our cortex-wise mediation findings are in line with the few studies that have examined genetics-brain-cognition relationships. We observed a consistent mediation particularly in frontal regions, such as the DLPFC, as well as the anterior cingulate cortex, posterior cingulate cortex, and medial temporal lobes, where cortical structure mediated the effect of PSi on g-factor. Our results are spatially similar to twin-based heritability studies. In virtually identical regions, cortical gray matter volume mediated the association of the genetic influence on g-factor (Gray and Thompson 2004). More recently, frontotemporal cortical thickness, as well as change in cortical thickness during adolescence, was also demonstrated to mediate the genetic association with full-scale IQ (Schmitt et al. 2019). Therefore, the genetic influence estimated by GWAS meta-analysis derived PSi or twin-based heritability both support a shared associations of genetics and brain structure on intelligence. Furthermore, a meta-analysis across four independent samples found a weak but consistent mediation effect among polygenic scores derived from an education attainment GWAS (Davies et al. 2016), total brain volume, and cognitive performance (Elliott et al. 2018b). These previous findings on total brain volume mediation are consistent with our results given the relatively strong, GWAS-derived, genetic correlation between intelligence and educational attainment (rg~0.70) (Rietveld et al. 2013; Savage et al. 2018). Our mediation findings are also consistent with the association between intelligence and brain activation during cognitive demand in lateral prefrontal, insular, parietal, temporal, motor, as well as posterior and anterior cingulate regions (Basten et al. 2015; Hearne et al. 2016; Saxe et al. 2018). Since we observed a more specific mediation effect in frontotemporal and insular regions, it could be speculated that the relatively weak total brain volume mediation could be too general of a phenotype.
There are some important limitations to this study. Mediation analyses inherently imply causal inference; however, we are cautious of this implication. We had a strong a priori hypothesis of the direction of our mediation models: genetics likely determine brain structure (and not vice versa), and brain structure likely determines g-factor; however, in both IMAGEN and IntegraMooDS, the PSi only explained 3–5% of the variance in g-factor performance. We are only explaining a portion of the genetic contribution to intelligence (for example, the SNP-based heritability of general intelligence is approximately 20% (Marioni et al. 2014; Davies et al. 2018b; Savage et al. 2018)). Moreover, while we observed widespread and strongly significant associations among CT, SA, and g-factor, these structures explained only 2–3% of the variance of g-factor after including PSi as a covariate. Together, these explain why the maximum amount of the variance mediated by CT and SA was only around 0.7%. However, it should be noted that 0.7% represents 20–40% of the initial PSi association with g-factor in IMAGEN and IntegraMooDS, respectively. While in the context of imaging-genetics studies of behavior phenotypes, this amount of explained variance is not trivial, we cannot infer direct conclusions explaining g-factor performance. Therefore, our results should not be viewed as a causal gene-brain-behavior mechanism, but rather as an insight into cortical regions that directly related to PSi and g-factor performance that are more specific than either of these associations alone. Furthermore, our subgroups were too small to make definitive conclusions about the patient groups. Within IntegraMooDS, our results were consistent across patient and relative subgroups suggesting the genetic association is independent from psychiatric diagnosis; nevertheless, these results need to be confirmed in larger patient samples. Moreover, both our samples were of European descent; therefore, we are unable to assess the effect of PSi in other ethnic subgroups. Finally, there is a known interaction among age, surface area, cortical thickness, and intelligence (Narr et al. 2006; Karama et al. 2014). We observed consistent genetic effects on cortical structure in adolescents and adults. However, a sample designed to assess across-the-lifespan effects would be needed to assess any neurodevelopmental effects.
Our findings support a direction of effect in which GWAS-derived PSi affect cortical structure, which in turn correlates with g-factor performance. In particular, it supports an intermediate role of cortical morphology in the relationship between cumulative genetic load for general intelligence and g-factor performance. Although polygenic scores are unlikely to account for all of the genetically explained variance in g-factor performance, PSi appears to be an interesting factor collectively influencing cortical structure and neurocognition.
Funding
This research was supported by the German Ministry for Education and Research (BMBF) grants NGFNplus MooDS 01GS08148, e:Med program O1ZX1314B and O1ZX1314G as well as Forschungsnetz AERIAL 01EE1406A and 01EE1406B. Furthermore, this work is supported by an NARSAD Distinguished Investigator Grant to H.W. and S.R. B.O.V. is funded by BMBF grant 01EE1407 and T.A.L. is funded by DFG grant Wa 1539/11–1, ER 724/4–1. Furthermore, this work received support from the following sources: the European Union-funded FP6 Integrated Project IMAGEN (reinforcement-related behavior in normal brain function and psychopathology) (LSHM-CT-2007-037286), the Horizon 2020 funded ERC Advanced Grant “STRATIFY” (brain-network-based stratification of reinforcement-related disorders) (695313), ERANID (understanding the interplay between cultural, biological, and subjective factors in drug use pathways) (PR-ST-0416-10004), BRIDGET (JPND: BRain Imaging, cognition Dementia and next generation GEnomics) (MR/N027558/1), the FP7 projects IMAGEMEND(602450; IMAging GEnetics for MENtal Disorders) and MATRICS (603016), the Innovative Medicine Initiative Project EU-AIMS (115300–2), the Medical Research Council Grant “c-VEDA” (Consortium on Vulnerability to Externalizing Disorders and Addictions) (MR/N000390/1), the Swedish Research Council FORMAS, the Medical Research Council, the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London, the Bundesministeriumfür Bildung und Forschung (BMBF grants 01GS08152; 01EV0711; eMED SysAlc01ZX1311A; Forschungsnetz AERIAL 01EE1406A, 01EE1406B), the Deutsche Forschungsgemeinschaft (DFG grants, SM 80/7–2, SFB 940/2), the Medical Research Foundation and Medical research council (grant MR/R00465X/1). Further support was provided by grants from: ANR (project AF12-NEUR0008–01—WM2NA and ANR-12-SAMA-0004), the Fondation de France, the Fondation pour la Recherche Médicale, the Mission Interministérielle de Lutte-contre-les-Drogues-et-les-Conduites-Addictives (MILDECA), the Fondation pour la Recherche Médicale (DPA20140629802), the Fondation de l’Avenir, Paris Sud University IDEX 2012; the National Institutes of Health, Science Foundation Ireland (16/ERCD/3797), USA (axon, testosterone, and mental health during adolescence; RO1 MH085772-01A1), and by NIH Consortium grant U54 EB020403, supported by a cross-NIH alliance that funds Big Data to Knowledge Centers of Excellence.
Notes
None declared. Conflict of Interests: T.B. has served as an advisor or consultant to Bristol-Myers Squibb, Desitin Arzneimittel, Eli Lilly, Medice, Novartis, Pfizer, Shire, UCB, and Vifor Pharma; he has received conference attendance support, conference support, or speaking fees from Eli Lilly, Janssen McNeil, Medice, Novartis, Shire, and UCB; and he is involved in clinical trials conducted by Eli Lilly, Novartis, and Shire; the present work is unrelated to these relationships. M.M. has been a member of the scientific advisory boards for the Lundbeck Foundation and Robert-Bosch-Stiftung, is a member of the medical-scientific editorial office of Deutsches Ärzteblatt, has received travel support from Shire Deutschland GmbH, and receives a salary from and holds shares in Life and Brain GmbH. A.M-L. discloses speaker and/or advisor or authorship fees from Astra Zeneca, Servier, Bristol-Myers Squibb GmbH & Co.KGaA, Desitin Arzneimittel GmbH, Defined Health, F. Hoffmann-La Roche Ltd, Lilly Deutschland GmbH, Gerson Lehrmann Group (GLG), Pricespective, Elsevier, Alexza Pharmaceuticals Inc., Outcome Sciences Inc., Pfizer Pharma GmbH, and Janssen-Cilag EMEA. H.W. received a speaker honorarium from Servier (2014). The other authors report no financial interest or potential conflict of interests.
References
Author notes
Shared first authorship



